Bluejay Diagnostics (BJDX) Total Current Liabilities (2021 - 2026)
Bluejay Diagnostics (BJDX) posted Total Current Liabilities of $1.4 million for Q1 2026, up 26.33% sequentially from $1.1 million in Q4 2025, and up 7.39% YoY from $1.3 million in Q1 2025.
Bluejay Diagnostics (BJDX) Total Current Liabilities (2021 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Total Current Liabilities for 6 years, with the latest figure at $1.4 million in Q1 2026.
- Quarterly Total Current Liabilities rose 7.39% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 7.39% YoY) and the FY2025 annual result came in at $1.1 million, up 38.11% from the prior year.
- Total Current Liabilities rose to $1.4 million in Q1 2026 per BJDX's latest filing, from $1.1 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $2.8 million in Q3 2023 and troughed at $810368.0 in Q4 2024.
- A 5-year average of $1.5 million and a median of $1.4 million in 2026 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities jumped 157.43% in 2022, then tumbled 64.29% in 2024.
- Over 5 years, Total Current Liabilities stood at $1.6 million in 2022, then rose by 7.99% to $1.8 million in 2023, then plunged by 54.25% to $810368.0 in 2024, then soared by 38.11% to $1.1 million in 2025, then rose by 26.33% to $1.4 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $1.4 million, $1.1 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Bluejay Diagnostics | 1.91 Mn | 1.91 Mn | - | 2.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.12 Mn |
| Mar 31, 2026 | 1.41 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 810,368.00 |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 2.06 Mn |
| Mar 31, 2024 | 1.53 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 2.80 Mn |
| Jun 30, 2023 | 1.83 Mn |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.64 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 979,590.00 |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 637,162.00 |